Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneCell International is a biotechnology company specializing in the processing and cryopreservation of stem cells from various sources, including umbilical cord blood, cord tissue, dental pulp, and adipose tissue. The company operates a state-of-the-art laboratory in Miami, Florida, where it provides families with long-term storage solutions for biological materials that may be used in future cellular therapies. GeneCell's services are designed to preserve potent stem cells that can potentially treat a wide range of hematological, oncology, and regenerative medicine conditions. In addition to its banking operations, the company is involved in research initiatives to advance the clinical utility of adult stem cells.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gene-Cell.